Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by MRI

Background —Inflammation and myocardial necrosis play important roles in ischemia/reperfusion injury after coronary artery occlusion and recanalization. The detection of inflammatory activity and the extent of myocardial necrosis itself are of great clinical and prognostic interest. We developed a dual, non-invasive imaging approach using molecular magnetic resonance imaging (MRI) in an in vivo mouse model of myocardial ischemia and reperfusion. Methods and Results —Ischemia/reperfusion injury was induced in 10 week old C57BL/6N mice by temporary ligation of the “left anterior descending coronary artery“(LAD). Activated platelets were targeted with a contrast agent consisting of microparticles of iron oxide (MPIO) conjugated to a single-chain antibody directed against a ligand-induced binding site (LIBS) on activated glycoprotein (GP)IIb/IIIa (=LIBS-MPIO). After injection and imaging of LIBS-MPIO, late gadolinium enhancement (LGE) was used to depict myocardial necrosis; these imaging experiments were also performed in P2Y 12-/- mice. All imaging results were correlated to immunohistochemistry findings. Activated platelets were detectable by MRI via a significant signal effect caused by LIBS-MPIO in the area of LAD occlusion two hours after reperfusion. In parallel, LGE identified the extent of myocardial necrosis. Immunohistochemistry confirmed that LIBS-MPIO significantly bound to microthrombi in reperfused myocardium. Only background-binding was found in P2Y 12-/- mice. Conclusions —Dual molecular imaging of myocardial ischemia/reperfusion injury allows characterization of platelet-driven inflammation by LIBS-MPIO as well as myocardial necrosis by LGE. This non-invasive imaging strategy is of clinical interest for both diagnostic and prognostic purposes, and highlights the potential of molecular MRI for characterizing ischemia/reperfusion injury. glycoprotein (GP)IIb/IIIa (=LIBS-MPIO). After injection and imaging of LIBS--MPMPMPIOIOO,, lalaatetete gadolinium enhancement (LGE) was used to depict myocardial necrosis; these imaging experiments were also performed in P2Y 12-/- mice. All imaging results were correlated to mmmmumumunonohiiststtoococheemimiststryry finindidngngs.s. Acctivavteed plataeleleetetss werere ddetecttababable bby y MMRI viia a a signgnifiicicant iiignnnala effect cacauusseed bbbyyy LILILIBSBSBS-M-M-MPIPIIOO O ininn tthhe aareea offf LLLADDD oocccccluuusisionoon ttwowo hoouoursrss aaaftftererr reepepeerrfufuusisionoon.. In f papaararalllllell,, LGLGE E E ididenenentiififieeded thehe eeextxtxtenent ofofo mmmyyoyocacaardddiaial nneececrroossisis.s. IImmmmmuununoohistotochcheeemmimiststryryy ccononffirrmrmeedd tttha LIBSBS-MMPIPIOO sisigngifficicanatlyy bobounundd toto microroththrorombmbi i in rrepepererfufusesed d mymyococarardiiumum. OnOnlyl bbacakgkgrorounud-d-binding g wass fofofoununund dd ininin PPP2Y2Y2 12112-/--/-/- mmicicicee.

[1]  P. Kellman,et al.  Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure , 2013, Journal of the American Heart Association.

[2]  G. Hindricks,et al.  Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.

[3]  R. Senior,et al.  The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. , 2013, European heart journal.

[4]  W. Daniel,et al.  A myocardial ischemia- and reperfusion-induced injury is mediated by reactive oxygen species released from blood platelets , 2013, Platelets.

[5]  C. Bode,et al.  In Vivo Detection of Activated Platelets Allows Characterizing Rupture of Atherosclerotic Plaques with Molecular Magnetic Resonance Imaging in Mice , 2012, PloS one.

[6]  J. Schulz-Menger,et al.  Functional and Morphological Cardiac Magnetic Resonance Imaging of Mice Using a Cryogenic Quadrature Radiofrequency Coil , 2012, PloS one.

[7]  M. Olschewski,et al.  Novel Single-Chain Antibody-Targeted Microbubbles for Molecular Ultrasound Imaging of Thrombosis: Validation of a Unique Noninvasive Method for Rapid and Sensitive Detection of Thrombi and Monitoring of Success or Failure of Thrombolysis in Mice , 2012, Circulation.

[8]  M. Majmudar,et al.  Cardiovascular Molecular Imaging: The Road Ahead , 2012, The Journal of Nuclear Medicine.

[9]  Ahmed Tawakol,et al.  PET/MRI of inflammation in myocardial infarction. , 2012, Journal of the American College of Cardiology.

[10]  C. Higgins,et al.  Delayed Contrast Enhancement on MR Images of Myocardium , 2011 .

[11]  C. Bode,et al.  Molecular Magnetic Resonance Imaging Allows the Detection of Activated Platelets in a New Mouse Model of Coronary Artery Thrombosis , 2011, Investigative radiology.

[12]  U. Walter,et al.  Phosphorylation of Vasodilator-Stimulated Phosphoprotein Prevents Platelet-Neutrophil Complex Formation and Dampens Myocardial Ischemia-Reperfusion Injury , 2011, Circulation.

[13]  A. Dart,et al.  Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[14]  Matthias Nahrendorf,et al.  Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.

[15]  P. Conley,et al.  Role of the P2Y12 Receptor in the Modulation of Murine Dendritic Cell Function by ADP , 2010, The Journal of Immunology.

[16]  R. Jaffe,et al.  Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. , 2010, JACC. Cardiovascular interventions.

[17]  Valerie A. Norton,et al.  Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP. , 2010, Magnetic resonance imaging.

[18]  M. Mirabet,et al.  Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts , 2010, Thrombosis and Haemostasis.

[19]  R. Virmani,et al.  Microvascular obstruction: underlying pathophysiology and clinical diagnosis. , 2010, Journal of the American College of Cardiology.

[20]  R. Choudhury,et al.  An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide☆ , 2010, Atherosclerosis.

[21]  S. Aime,et al.  Current concepts on hyperpolarized molecules in MRI. , 2010, Current opinion in chemical biology.

[22]  B. Gersh,et al.  Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.

[23]  Claes Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[24]  K. Peter,et al.  Single-chain antibodies as diagnostic tools and therapeutic agents , 2009, Thrombosis and Haemostasis.

[25]  E. Antman,et al.  Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.

[26]  M. Olschewski,et al.  Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.

[27]  S. Neubauer,et al.  Visualization of Activated Platelets by Targeted Magnetic Resonance Imaging Utilizing Conformation-Specific Antibodies against Glycoprotein IIb/IIIa , 2008, Journal of Vascular Research.

[28]  C. Bode,et al.  A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. , 2008, The Journal of clinical investigation.

[29]  C. Kramer,et al.  Magnetic resonance for the assessment of myocardial viability , 2006, Current opinion in cardiology.

[30]  C. Bode,et al.  Conformation-Specific Blockade of the Integrin GPIIb/IIIa: A Novel Antiplatelet Strategy That Selectively Targets Activated Platelets , 2006, Circulation research.

[31]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[32]  M. Little,et al.  Single-chain Antibodies for the Conformation-specific Blockade of Activated Platelet Integrin Α Iib Β 3 Designed by Subtractive Selection from Naïve Human Phage Libraries , 2022 .

[33]  Gerhard Adam,et al.  Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. , 2004, Radiology.

[34]  R. Kim,et al.  Magnetic resonance imaging for the assessment of myocardial viability , 2004, Journal of magnetic resonance imaging : JMRI.

[35]  C. Bode,et al.  Reversibility versus Persistence of GPIIb/IIIa Blocker-Induced Conformational Change of GPIIb/IIIa (αIIbβ3, CD41/CD61) , 2004, Journal of Pharmacology and Experimental Therapeutics.

[36]  J. Lima,et al.  Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. , 2003, Journal of the American College of Cardiology.

[37]  P. Conley,et al.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. , 2003, The Journal of clinical investigation.

[38]  E. Topol,et al.  Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. , 2001, The American journal of cardiology.

[39]  H. Ito No reflow phenomenon in coronary heart disease. , 2001, Journal of cardiology.

[40]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[41]  E. Antman,et al.  Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.

[42]  P. Kistler,et al.  Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients with Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death , 2010 .

[43]  M. Gawaz,et al.  [The role of platelets for the pathophysiology of acute coronary syndromes]. , 2006, Hamostaseologie.

[44]  L. Becker Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.